Onco-Innovations Limited Announces Non-Brokered Private Placement

Onco-Innovations Limited has announced a non-brokered private placement involving up to 243,903 units at $1.64 per unit, aiming for gross proceeds of $400,000. Each unit includes a common share and a warrant, allowing the purchase of an additional share at $2.05 over 36 months. An administrative fee of 1.0% in shares will be granted to a third-party advisor unrelated to the company.

The closure of this placement depends on regulatory approvals. The funds raised are intended for corporate and operational purposes, supporting ongoing research and development. Issued securities will adhere to a hold period of four months and one day.

Additionally, Onco's board has granted 119,785 stock options and 960,000 restricted share units per their equity plan. These initiatives highlight the company's ongoing commitment to oncology advancement.